Trautner Simon, Amtorp Ole, Boesgaard Soren, Andersen Claus B, Galbo Henrik, Haunsoe Stig, Sheykhzade Majid
Department of Cardiology, The Danish National Hospital, Rigshospitalet, Blegdamsvej 9, Copenhagen, DK-2100, Denmark.
Eur J Pharmacol. 2006 May 10;537(1-3):143-54. doi: 10.1016/j.ejphar.2006.03.028. Epub 2006 Mar 17.
We tested the hypothesis that arterial reactivity to noradrenaline is augmented in congestive heart failure (CHF), which could contribute to the deleterious changes in peripheral vascular resistance and compliance in this condition. From male Wistar rats with post-infarction CHF and sham-operated rats, skeletal muscle conductance and resistance arteries (mean lumen diameters: 514 and 186 microm) were isolated and mounted on wire myographs, and wall tension was recorded in response to cumulative application of acetylcholine and noradrenaline to the vessel segments. In a subset of experiments, wall tension and cytosolic free calcium ion concentration Ca(2+) were recorded simultaneously during noradrenaline application, using wire myography and the FURA-2 technique. No significant differences were found in the arterial baseline levels of Ca(2+) or tension between CHF and sham rats. In the resistance arteries of CHF rats, the noradrenaline-induced increases in Ca(2+) were significantly enhanced (P=0.003). Despite the augmented Ca(2+) levels, the tension responses to noradrenaline were unaltered in these arteries. In the conductance arteries, there were no significant differences in noradrenaline-induced Ca(2+) or tension responses between CHF and control rats. CHF did not alter vascular morphology or change vascular relaxations to acetylcholine in either type of artery. In conclusion, these results do not support the contention that arterial reactivity to noradrenaline is augmented in the skeletal muscle vascular bed in CHF. On the contrary, the unchanged contractile responsiveness in the resistance arteries despite the enhanced levels of Ca(2+) during noradrenaline application suggests that the contractile function of these vessels is compromised in CHF. Neither vascular remodeling, endothelial dysfunction nor changes in baseline vascular tone could be demonstrated in the skeletal muscle vascular bed of this animal model of heart failure.
在充血性心力衰竭(CHF)中,动脉对去甲肾上腺素的反应性增强,这可能导致该病症中外周血管阻力和顺应性的有害变化。从心肌梗死后患CHF的雄性Wistar大鼠和假手术大鼠中,分离出骨骼肌传导动脉和阻力动脉(平均管腔直径分别为514和186微米),并安装在线肌张力测定仪上,记录血管段对乙酰胆碱和去甲肾上腺素累积应用的壁张力反应。在一部分实验中,应用线肌张力测定法和FURA - 2技术,在应用去甲肾上腺素期间同时记录壁张力和胞质游离钙离子浓度Ca(2 +)。CHF大鼠和假手术大鼠之间,Ca(2 +)的动脉基线水平或张力未发现显著差异。在CHF大鼠的阻力动脉中,去甲肾上腺素诱导的Ca(2 +)增加显著增强(P = 0.003)。尽管Ca(2 +)水平升高,但这些动脉对去甲肾上腺素的张力反应未改变。在传导动脉中,CHF大鼠和对照大鼠之间,去甲肾上腺素诱导的Ca(2 +)或张力反应没有显著差异。CHF在两种类型的动脉中均未改变血管形态或改变对乙酰胆碱的血管舒张反应。总之,这些结果不支持CHF时骨骼肌血管床中动脉对去甲肾上腺素的反应性增强这一论点。相反,尽管在应用去甲肾上腺素期间Ca(2 +)水平升高,但阻力动脉中的收缩反应性未改变,这表明这些血管的收缩功能在CHF中受损。在这个心力衰竭动物模型的骨骼肌血管床中,未发现血管重塑、内皮功能障碍或基线血管张力的变化。